The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Bordetella pertussis

Bordetella Pertussis is the causative agent of whooping cough, a highly contagious respiratory disease, known for uncontrollable, violent coughing which often makes it hard to breathe.

Our Bordetella pertussis product range includes several formats of pertussis toxin and also purified FHA antigen. In addition to applications for vaccine research and within diagnostics kits, our toxin is highly active and widely used in cell biology studies of GTP binding proteins.

Bordetella pertussis Background

Bordetella Pertussis is a gram-negative coccobacillus that belongs to the genus Bordetella. First described in 1906, B. pertussis infection causes a highly contagious respiratory disease in humans, known as whooping cough or pertussis. The organism is thought to be transmitted between humans by aerosol droplets but does not survive for long periods in the environment.

Pertussis infection is localised to the respiratory tract and usually gives causes general malaise followed by a paroxysmal period of coughing lasting 1-6 weeks. Reports suggest that infection may cause an increase in lymphocyte numbers, causing confusion and other neurological symptoms. These symptoms may be caused by B. pertussis virulence factors (Hewlett, EL), which include pertussis toxin, filamentous haemagglutinin, pertactin, adenylate cyclase toxin and tracheal cytotoxin. Currently, the precise mechanism of pathogenesis is still unknown and the relevance of these and other potential virulence factors is still to be determined (CDC).

Until the introduction of a successful vaccine in the 1940s, whooping cough was a common illness in young children worldwide and a major cause of childhood mortality. Subsequent widespread vaccination resulted in a significant decrease in the number of cases worldwide. However, in recent years the number of reported cases have been rising in the developed world. Cases of infection have also been reported in adolescents, young adults and infants that are too young to vaccinate. These reports raise concerns regarding the efficacy of the vaccine currently in use and the possibility of waning immunity in vaccinated individuals (Hartzell, JD).

Currently, diagnosis of infection is achieved using serological techniques and molecular subtyping. However, correct diagnosis is complicated by the fact that symptoms of B. pertussis resemble other respiratory diseases in the early stages, driving a need for more sensitive methods of detection and diagnosis.

References

  1. Hewlett, EL (2014). Pertussis Pathogenesis—What We Know and What We Don’t Know. J Infect Dis.209(7): 982–985.
  2. Centers for Disease Control and Prevention: Pertussis (whooping cough)
  3. Hartzell, JD and Blaylock, JM (2014). Whooping cough in 2014 and beyond: an update and review. Chest.146(1):205-214.

Bordetella pertussis Antigens

The Native Antigen Company offers key Bordetella pertussis antigens including the pertussis toxin lyophilised, in glycerol and frozen, filamentous haemagglutinin (FHA) and Pertactin/P69.

Pertussis toxin is most commonly used in immunoassay manufacture and cell biologists studying GTP receptor biology. To meet the variety of needs, we offer pertussis toxin in a range of different formats.

FHA is increasingly used in immunoassays, monitoring responses to pertussis vaccination.

Bordetella pertussis Antibodies

The Native Antigen Company is pleased to offer a rabbit polyclonal antibody against pertussis toxin.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Monkeypox; 3 months on

It has been 3 months since a new, unusually widespread outbreak of Monkeypox was first identified. What was normally a virus confined to limited infections in the West African continent is becoming a global health concern.   What have we learned about this virus...

COVID-19 Underlines the Need for Universal Vaccines

This article was originally published on Clinical Lab Manager. In recent history, humanity has witnessed numerous emerging viral diseases, including the SARS, MERS, and SARS-2 coronaviruses, as well as HIV, Zika, Ebola, and H1N1 and H3N2 influenza. None have tested...

Tick-Borne Diseases: The Need for Integrated Approaches to Human-Animal Diagnosis

This article has been published in Volume 8, Issue 3 of International Animal Health Journal. Ticks are responsible for a diverse group of neglected, and rapidly expanding diseases, affecting humans, companion animals and livestock. A growing understanding of tick-host...

The Continued Challenges of Flavivirus Serology

This article was originally published on the Science Advisory Board. Flaviviruses are a genus of positive-sense RNA viruses, largely transmitted by mosquito and tick vectors that cause infections, including yellow fever, dengue, the Zika virus, West Nile virus,...

The Role of Serology in Tracking COVID-19 Mutations

This article was originally published on Clinical Lab Products. As SARS-CoV-2 began its global proliferation in early 2020, scientists hastened to investigate its biology, develop diagnostic tests, and design candidate vaccines, marking one of the most...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

2 + 13 =